The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. The index has shown a price loss of -55.87% this year. Over the last six months, there has been a stronger performance of -81.90%. The price of BTAI leaped by -64.99% during the last 30 days period. For the last 5-days stocks have slided -49.39%.
BioXcel Therapeutics Inc experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $3.96 on 02/16/24, while the lowest price for the same period was registered at $0.18 on 02/07/25.
52-week price history of BTAI Stock
Examining the 52-week high and low prices can provide valuable insights into a stock’s current status and future performance. BioXcel Therapeutics Inc’s current trading price is -95.84% away from its 52-week high, while its distance from the 52-week low is -10.33%. The stock’s price range during this time has been between $0.18 and $3.96. The trading volume for the Healthcare sector company’s shares reached about 4.53 million for the day, which was higher than the average daily volume of 1.81 million over the last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
BioXcel Therapeutics Inc (BTAI) has experienced a quarterly decline of -75.62% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 8.19M and boasts a workforce of 74 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.4874, with a change in price of -0.5150. Similarly, BioXcel Therapeutics Inc recorded 1,347,184 in trading volume during the last 100 days, posting a change of -75.74%.
BTAI Stock Stochastic Average
Today, BioXcel Therapeutics Inc’s raw stochastic average for the past 50 days stands at 1.19%, indicating a decline from the raw stochastic average of the last 20 days, which was 1.81%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 4.50% and 4.68% respectively.
